Related Content
January 27, 2011 – The U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices ...
January 20, 2011 – European CE mark approval was granted to expand the indication of Abbott’s Xience Prime everolimus ...
January 10, 2011 – European CE mark approval was announced today for the Abbott, Absorb drug-eluting bioresorbable ...
October 13, 2010 – The anti-obesity drug sibutramine will be withdrawn from the U.S. market after a study found it had ...
September 23, 2010 - Results from the second stage of a trial studying a bioresorbable vascular scaffold were announced ...
September 22, 2010 – Coronary artery disease, a leading cause of death and poor quality of life worldwide, can often ...
September 17, 2010 - The Cardiovascular Research Foundation's 22nd annual Transcatheter Cardiovascular Therapeutics (TCT ...
In addition to the FDA-cleared Gore Helex and the AGA Amplatzer transcatheter devices for atrial septal defects (ASDs) ...
June 3, 2010 – Six-month data from the first 45 patients enrolled in the second stage of a trial for a bioresorbable ...
June 2, 2010 – A portable point-of-care prothrombin time/international normalized ratio (PT/INR) analyzer was released ...